Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction

Circulation

Volumn 103, Issue 5, 2001, Pages 736-742

  Jin, Hongkui ^a   Yang, Renhui ^a   Awad, Tarif A ^b   Wang, Fay ^a   Li, Wei ^a   Williams, Simon Peter ^a   Ogasawara, Annie ^a   Shimada, Brian ^b   Williams, P Mickey ^a   De Feo, Gianfranco ^b   Paoni, Nicholas F ^a  

^a GENENTECH INC   (United States)

^b Thermo Fisher Scientific   (United States)

Author keywords

Cardiomyopathy; Genes; Heart failure; Molecular biology

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; HEART FAILURE; HEART INDEX; HEART PROTECTION; HEART STROKE VOLUME; HEART WEIGHT; MALE; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0035814781     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.5.736     Document Type: Article

References (23)

1. Influence of chronic captopril therapy on the infarcted left ventricle of the rat
2. Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril
3. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction
4. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction
5. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
6. Progressive ventricular remodeling in rats with myocardial infarction
7. Influence of chronic captopril therapy on the infarcted left ventricle of the rat
8. Quantification of cardiac function by conventional and cine magnetic resonance imaging
9. Time course of spirapril-induced structural and functional changes after myocardial infarction in rats followed with magnetic resonance imaging
10. Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared to bolus injection
11. Genome-wide expression monitoring in Saccharomyces cerevisiae
12. Development and validation of real-time quantitative reverse transcription-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro
13. Human heart generates complement proteins that are upregulated and activated after myocardial infarction
14. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
15. Endotoxin and immune activation in chronic heart failure: A prospective cohort study
16. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro
17. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β
18. Defective lipid metabolism in the failing heart
19. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure
20. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart
21. Angiotensin II stimulated expression of transforming growth factor-beta 1 in cardiac fibroblasts and myofibroblasts
22. Angiotensin II, transforming growth factor-beta 1 and repair in the infarcted heart
23. Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: Effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade